Is the 4MGS a Useful Outcome Measure Post-PPCI
Completed
- Conditions
- Acute Myocardial Infarction
- Registration Number
- NCT02261324
- Lead Sponsor
- Royal Brompton & Harefield NHS Foundation Trust
- Brief Summary
This study aims to assess usual walking speed (4-metre gait speed) in patients undergoing primary percutaneous coronary intervention (PCI) for acute myocardial infarction and to assess whether this can predict future cardiovascular events and death.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 560
Inclusion Criteria
- Any patient hospitalised with an acute myocardial infarction who has undergone primary percutaneous coronary intervention
- Capacity to consent
- Able to walk
- Age over 18 years
Exclusion Criteria
- Significant co-morbidities that would limit exercise capacity or make exercise unsafe (e.g. neuromuscular disease, severe hip/lower limb joint pain, peripheral vascular disease, lower limb amputation)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mortality rate 1 year
- Secondary Outcome Measures
Name Time Method Occurrence of cardiovascular events 1 and 5 years Need for repeat revascularisation 1 and 5 years Health resource usage 1 and 5 years All-cause mortality 5 years Cardiovascular death 1 and 5 years
Trial Locations
- Locations (1)
Harefield Hospital
🇬🇧Harefield, Middlesex, United Kingdom